Skip to main content

iPSC-Derived Microglia

Quick Facts

FeatureInformation
Cell TypeHuman Microglia Derived from iPSCs
OriginPrimitive Myeloid Lineage from iPSCs
SpeciesHuman
Growth ModeSemi-Adherent
ProliferationLimited
Typical Maturation4-8 Weeks
Biosafety LevelBSL-2

Overview

iPSC-derived microglia are human microglia generated by differentiating induced pluripotent stem cells (iPSCs) through developmental pathways that mimic embryonic yolk sac hematopoiesis. Unlike neurons, astrocytes, and oligodendrocytes, microglia originate from primitive erythromyeloid progenitors rather than the neuroectoderm.

These cells provide a physiologically relevant, patient-specific model for studying neuroinflammation, innate immune responses, phagocytosis, and neuron-microglia interactions. They have become indispensable for modeling neurodegenerative and neurodevelopmental disorders.


Biological Significance

Microglia are the resident innate immune cells of the central nervous system.

Major functions include:

  • Immune surveillance
  • Phagocytosis of pathogens and cellular debris
  • Synaptic pruning
  • Cytokine and chemokine secretion
  • Regulation of neuroinflammation
  • Tissue repair following CNS injury
  • Maintenance of brain homeostasis
  • Interaction with neurons, astrocytes, and oligodendrocytes

Developmental Origin

Somatic Cell

Cellular Reprogramming

Induced Pluripotent Stem Cell

Mesoderm

Hemogenic Endothelium

Primitive Hematopoietic Progenitor

Erythromyeloid Progenitor (EMP)

Microglial Precursor

iPSC-Derived Microglia

Unlike other CNS cell types, microglia originate from primitive yolk sac-derived myeloid progenitors rather than the neuroectoderm.


Unique Features

Compared with immortalized microglial cell lines and primary rodent microglia, iPSC-derived microglia offer several advantages:

  • Human-specific microglial biology
  • Patient-specific genetics
  • Unlimited renewable cell source
  • Physiological immune responses
  • Suitable for CRISPR genome editing
  • Compatible with brain organoids
  • Ideal for neuron-microglia co-culture
  • Strong translational relevance

Morphology

Homeostatic Microglia

  • Small cell body
  • Thin ramified processes
  • Highly branched morphology

Activated Microglia

  • Enlarged soma
  • Amoeboid appearance
  • Retraction of cellular processes

Phagocytic Microglia

  • Rounded morphology
  • Vacuolated cytoplasm
  • Increased granularity

Cell Markers

Core Microglial Markers

MarkerFunction
IBA1 (AIF1)Cytoskeletal protein
TMEM119Microglia-specific marker
P2RY12Homeostatic microglia marker
CX3CR1Chemokine receptor
TREM2Phagocytosis and lipid sensing

Additional Markers

MarkerFunction
CD11bMyeloid marker
CD68Lysosomal marker
PU.1Myeloid transcription factor

Common Validation Panel

IBA1

TMEM119

P2RY12

CX3CR1


Functional Characterization

Common functional assays include:

  • Phagocytosis assays
  • Cytokine secretion
  • Calcium imaging
  • Migration assays
  • Synaptic pruning studies
  • Oxidative stress assays
  • Neuron-microglia co-cultures
  • Brain organoid integration

Disease Modeling Applications

iPSC-derived microglia are widely used for studying human neurological disorders.

Neurodegenerative Diseases

Examples include:

  • Alzheimer's disease
  • Parkinson's disease
  • Amyotrophic Lateral Sclerosis (ALS)
  • Huntington's disease
  • Multiple sclerosis

Common readouts include:

  • Amyloid-β uptake
  • α-Synuclein uptake
  • Cytokine secretion
  • Disease-associated microglia (DAM) phenotypes
  • Oxidative stress
  • Phagocytic activity

Neurodevelopmental Disorders

Examples include:

  • Autism spectrum disorder
  • Schizophrenia
  • Rett syndrome

Applications include:

  • Synaptic pruning
  • Immune signaling
  • Brain development
  • Neuron-glia communication

Brain Organoid Applications

iPSC-derived microglia are increasingly incorporated into:

  • Cortical organoids
  • Midbrain organoids
  • Brain assembloids

Applications include:

  • Neurodevelopment
  • Synaptic remodeling
  • Neuroimmune interactions
  • Disease modeling

Drug Discovery Applications

Widely used for:

  • Neuroinflammation screening
  • Immunomodulatory drug discovery
  • Neuroprotection studies
  • Toxicology testing
  • Target validation

Gene Editing Applications

Frequently combined with:

  • CRISPR-Cas9
  • Base editing
  • Prime editing

Applications include:

  • TREM2 studies
  • APOE studies
  • Functional genomics
  • Mutation correction
  • Isogenic controls

Advantages

  • Human-derived cells
  • Patient-specific genetics
  • Human microglial biology
  • Physiological immune responses
  • Unlimited renewable source
  • Compatible with organoids and co-cultures
  • Strong translational relevance

Limitations

  • Long differentiation timelines
  • Batch variability
  • Immature phenotypes possible
  • Expensive culture systems
  • Complex developmental protocols
  • Maturation depends on the surrounding microenvironment

Comparison with BV2 Cells

FeatureiPSC-Derived MicrogliaBV2 Cells
SpeciesHumanMouse
Patient-SpecificYesNo
Physiological RelevanceHighModerate
TMEM119 ExpressionHighLimited
Disease ModelingExcellentModerate
Translational RelevanceExcellentModerate

Key Takeaways

  • iPSC-derived microglia are generated by recapitulating embryonic yolk sac myelopoiesis rather than neural differentiation.
  • They closely model human microglial biology while retaining patient-specific genetics.
  • They are essential for studying neuroinflammation, phagocytosis, synaptic pruning, and neuron-microglia interactions.
  • They integrate readily into neuron co-cultures and brain organoids, enabling advanced human CNS disease models.
  • Their physiological relevance makes them one of the most valuable tools for modern neuroimmunology research.

References

  • Muffat J et al. Efficient derivation of microglia-like cells from human pluripotent stem cells. Nature Medicine (2016).
  • Abud EM et al. iPSC-derived human microglia-like cells to study neurological diseases. Neuron (2017).
  • Haenseler W et al. A highly efficient human pluripotent stem cell microglia model. Nature Communications (2017).
  • Gosselin D et al. An environment-dependent transcriptional network specifies human microglia identity. Science (2017).